Why is Brooks Lab. falling/rising?

As of 24-Jul, Brooks Laboratories Ltd's stock price is flat, with no change at 155.20 (0.00%). The stock has underperformed its sector by 0.35% today, and the delivery volume has significantly decreased by 71.23% compared to the 5-day average, indicating falling investor participation. Over the past week, the stock has declined by 2.85%, while it has shown a positive return of 8.38% over the last month. Despite a strong performance over the past year with a return of 70.79%, the company's long-term fundamentals are weak, evidenced by a negative Return on Equity (ROE) of -10.2 and a poor growth rate in net sales of -2.90% over the last five years.
In the broader market context, the Sensex has remained relatively stable with a slight decline of 0.09% over the past week, which contrasts with Brooks Laboratories' more significant drop. While the stock has outperformed the benchmark over longer periods, its recent performance suggests a divergence from the overall market trend. The company's weak ability to service its debt and high valuation relative to its peers may be contributing factors to the stock's current stagnation, despite its historical performance and positive quarterly results.